id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-283279-1qcdnd1y	Barberio, Brigida	The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients During COVID-19 Pandemic: Is It Really a Problem?	2020-07-17		.txt	text/plain	662	42	51	title: The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients During COVID-19 Pandemic: Is It Really a Problem? 1 a evaluating the adherence to infusible biologic therapies, defined as receiving an infusion within ten weeks of the prior infusion, in patients with Inflammatory Bowel Disease (IBD) during the current Coronavirus disease 2019 (COVID-19) pandemic. 4, 5 For instance, at our Center, one week before the infusion, patients were contacted by email to reassure about the lack of risk in moving to the Hospital and the benefit of continuing medical therapy. We should explain to our patients with chronic diseases why it is important that they adhere to therapies which are relative safe and manageable despite the COVID-19 pandemic. Adherence of infusible biologics during the time of COVID-19 among patients with Inflammatory Bowel Disease: A nationwide VA cohort study	./cache/cord-283279-1qcdnd1y.txt	./txt/cord-283279-1qcdnd1y.txt